Matches in Wikidata for { <http://www.wikidata.org/entity/Q65473840> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65473840 description "clinical trial" @default.
- Q65473840 description "ensayu clínicu" @default.
- Q65473840 description "klinisch onderzoek" @default.
- Q65473840 description "клінічне випробування" @default.
- Q65473840 name "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 name "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 type Item @default.
- Q65473840 label "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 label "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 prefLabel "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 prefLabel "An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 P1132 Q65473840-EB7A356F-05CF-456E-84F7-4C4566444FE3 @default.
- Q65473840 P1476 Q65473840-A1B50A1A-A862-44CB-995F-01BC6E60D973 @default.
- Q65473840 P17 Q65473840-351F0CC9-3FB4-461D-8EC9-C6B3B81D9DA0 @default.
- Q65473840 P17 Q65473840-78A69594-397E-4565-9081-0DC70CDF916C @default.
- Q65473840 P2899 Q65473840-91ADFCA0-80A1-4047-854F-2B80E62D9D37 @default.
- Q65473840 P3098 Q65473840-1F4FD212-C9C5-45F4-8902-90A727E5E01B @default.
- Q65473840 P31 Q65473840-8EAC9B6A-C715-4D0D-B61B-4FF63E79B018 @default.
- Q65473840 P580 Q65473840-165B596E-B6D5-4C7A-A6AD-FB503C392878 @default.
- Q65473840 P582 Q65473840-B642CBE0-D968-4115-8C30-342AD64799A7 @default.
- Q65473840 P6099 Q65473840-544DB021-76D4-4510-ACD0-1F4612E5229F @default.
- Q65473840 P6153 Q65473840-05CBB9C8-5580-48CB-9219-FB321E00254D @default.
- Q65473840 P8363 Q65473840-59FCB460-9AFC-4D5D-A807-A6BD46027F5C @default.
- Q65473840 P1132 "+428" @default.
- Q65473840 P1476 "An Eight-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Efficacy, Safety and Tolerability of Two Fixed Doses (100 and 30 mg Once Daily) of Saredutant in Patients With Generalized Anxiety Disorder" @default.
- Q65473840 P17 Q30 @default.
- Q65473840 P17 Q408 @default.
- Q65473840 P2899 "+18" @default.
- Q65473840 P3098 "NCT00390533" @default.
- Q65473840 P31 Q30612 @default.
- Q65473840 P580 "2006-09-01T00:00:00Z" @default.
- Q65473840 P582 "2008-02-01T00:00:00Z" @default.
- Q65473840 P6099 Q42824827 @default.
- Q65473840 P6153 Q158205 @default.
- Q65473840 P8363 Q78089383 @default.